Third-Generation Transdermal Delivery Systems Containing Zidovudine: Effect of the Combination of Different Chemical Enhancers and a Microemulsion System
- 127 Downloads
This study aimed to examine the influence of the combination of chemical enhancers and a microemulsion on the transdermal permeation of zidovudine (AZT). Ethanol, 1,8-cineole, and geraniol were incorporated in a microemulsion. The droplet size, zeta potential, rheology, and SAXS analysis were performed. The permeation enhancer effect was evaluated using pig ear skin. Snake skin (Boa constrictor) treated with the formulations was also used as a stratum corneum model and studied by attenuated total reflectance-infrared spectroscopy. As a result, it was observed that the incorporation of the chemical enhancers promoted a decrease of the droplet size and some rheological modifications. The 1,8-cineole associated with the microemulsion significantly increased the permeated amount of AZT. Conversely, ethanol significantly increased the quantity of the drug retained in the skin. The probable mechanism for the cineole and ethanol effects was respectively: fluidization and increasing of the diffusion coefficient, and increasing of the partition coefficient. Surprising, geraniol + microemulsion drastically decreased both the permeated and the retained amount of AZT into the skin. Thus, the adequate association of microemulsion and chemical enhancers showed to be a crucial step to enable the topical or transdermal use of drugs.
KEY WORDSmicroemulsion chemical enhancer skin permeation transdermal delivery
We also acknowledge the Laboratório Nacional de Luz Síncroton (LNLS, Campinas SP, Brazil) for provision of synchrotron radiation facilities. We would like to thank SAXS staff for assistance in using beamline SAXS1 through the approved project number 20160301.
The authors thank CNPq/MCT and CT-FVA for their financial support and the LAFEPE for the AZT donation.
- 10.Montenegro L, Lai F, Offerta A, Sarpietro MG, Micicchè L, Maccioni AM, et al. From nanoemulsions to nanostructured lipid carriers: a relevant development in dermal delivery of drugs and cosmetics. J Drug Deliv Sci Technol. 2016;32:100–12. https://doi.org/10.1016/j.jddst.2015.10.003.CrossRefGoogle Scholar
- 11.Hathout RM, Nasr M. Transdermal delivery of betahistine hydrochloride using microemulsions: physical characterization, biophysical assessment, confocal imaging and permeation studies. Colloids Surf B Biointerfaces. 2013;110:254–60. https://doi.org/10.1016/j.colsurfb.2013.05.007.CrossRefPubMedGoogle Scholar
- 17.Carvalho ALM, da SJA, Lira AAM, Conceição TMF, Nunes R de S, de Albuquerque Junior RLC, et al. Evaluation of microemulsion and lamellar liquid crystalline systems for transdermal zidovudine delivery. J Pharm Sci. 2016;105:2188–93. https://doi.org/10.1016/j.xphs.2016.04.013.CrossRefPubMedGoogle Scholar
- 20.Formariz TP, Chiavacci LA, Sarmento VHV, Santilli CV, Tabosa do Egito ES, Oliveira AG. Relationship between structural features and in vitro release of doxorubicin from biocompatible anionic microemulsion. Colloids Surf B Biointerfaces. 2007;60:28–35. https://doi.org/10.1016/j.colsurfb.2007.05.017.CrossRefPubMedGoogle Scholar
- 21.Formariz TP, Chiavacci LA, Sarmento VHV, Franzini CM, Silva- AA, Scarpa MV, et al. Structural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidylcholine and their relationship with doxorubicin release. Colloids Surf B Biointerfaces. 2008;63:287–95. https://doi.org/10.1016/j.colsurfb.2007.12.021.CrossRefPubMedGoogle Scholar
- 28.Hathout RM, Mansour S, Geneidi AS, Mortada ND. Visualization, dermatopharmacokinetic analysis and monitoring the conformational effects of a microemulsion formulation in the skin stratum corneum. J Colloid Interface Sci. 2011;354:124–30. https://doi.org/10.1016/j.jcis.2010.10.025.CrossRefPubMedGoogle Scholar
- 29.Balázs B, Sipos P, Danciu C, Avram S, Soica C, Dehelean C, et al. ATR-FTIR and Raman spectroscopic investigation of the electroporation-mediated transdermal delivery of a nanocarrier system containing an antitumour drug. Biomed Opt Express. 2016;7:67–78. https://doi.org/10.1364/BOE.7.000067.CrossRefPubMedGoogle Scholar